NEW YORK: Pharmaceutical big Johnson & Johnson introduced on Tuesday it could stop promoting talc-based baby powder in the United States and Canada, the place sales had already been hit by altering client habits and fears the product causes most cancers.
The firm has lengthy denied claims that the talc powder it makes use of comprises cancer-causing asbestos, however has nonetheless been taken to court docket a number of hundreds of instances over the allegations.
In an announcement, Johnson & Johnson mentioned it remained “steadfastly confident” in the product’s security and would “vigorously” defend towards the lawsuits, noting that each one responsible verdicts handed towards the corporate have been overturned.
“As part of a portfolio assessment related to COVID-19, in March, Johnson & Johnson Consumer Health stopped shipping hundreds of items in the US and Canada to prioritize high-demand products and to allow for appropriate social distancing in manufacturing and distribution facilities,” the assertion mentioned.
It then determined to discontinue round 100 merchandise in the 2 international locations, together with the talc-based powder.
“Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising,” the corporate mentioned.
Existing shares of the powder shall be bought in the US and Canada till they run out, the corporate mentioned, and the product will stay on the market in international locations the place there may be “significantly higher consumer demand.”